Skip to main content
Equibles

FMS · Fresenius Medical Care AG · Webcasts, Transcripts & Audio

Track FMS — free

Use FMS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research FMS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$22.62 +0.12 (+0.53%) Q2 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$11.97B
Shares
532.22M
Volume · Oct 28 719.95K Avg daily vol (3M) 907.81K

Fresenius Medical Care AG Webcasts

Earnings calls, investor updates, investor days and conferences for Fresenius Medical Care AG (FMS), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-11-03
Fresenius Medical Care AG (FMS) Q3 2026 Earnings Call
Scheduled
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-08-04
Fresenius Medical Care AG (FMS) Q2 2026 Earnings Call Transcript
Positive tone TDAPA reimbursement US same-market treatment growth / referrals Care Enablement China and cost pressures
Revenue
4.86B EUR
▲ 1.4% YoY
Diluted EPS
0.81
▲ 5.2% YoY
Gross margin
27.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-05
Fresenius Medical Care AG (FMS) Q1 2026 Earnings Call Transcript
Positive tone China pressure on Care Enablement 5008X / HDF rollout TDAPA and US reimbursement
Revenue
4.61B EUR
▼ 5.5% YoY
Diluted EPS
0.43
▼ 17.3% YoY
Gross margin
25.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-24
Fresenius Medical Care AG (FMS) Q4 2025 Earnings Call Transcript
Confident tone TDAPA and phosphate binders contribution U.S. Care Delivery volumes and missed treatments FME25+ transformation and savings program
Revenue
5.07B EUR*
▼ 0.3% YoY
Gross margin
27.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-04
Fresenius Medical Care AG (FMS) Q3 2025 Earnings Call Transcript
Positive tone Care delivery volume and treatment growth FME Reignite strategy and capital allocation High-volume HDF rollout and 5008X machine
Revenue
4.88B EUR
▲ 2.6% YoY
Diluted EPS
0.94
▲ 28.8% YoY
Gross margin
25.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
Fresenius Medical Care AG (FMS) Q2 2025 Earnings Call Transcript
Positive tone Care Enablement segment performance Value-Based Care segment U.S. patient volume and flu impact
Revenue
4.79B EUR
▲ 0.5% YoY
Diluted EPS
0.77
▲ 20.3% YoY
Gross margin
25.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Date not confirmed
Fresenius Medical Care AG (FMS) Q1 2025 Earnings Call Transcript
Confident tone Care Enablement Margin Expansion Care Delivery Earnings & Phosphate Binders U.S. Same Market Treatment Growth & Referrals
Revenue
4.88B EUR
▲ 3.3% YoY
Diluted EPS
0.52
▲ 116.7% YoY
Gross margin
24.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
Date not confirmed
Fresenius Medical Care AG (FMS) Q4 2024 Earnings Call Transcript
Confident tone Care Delivery and Care Enablement margins FME25 transformation and cost program U.S. same market treatment growth and volumes
Revenue
5.08B EUR*
▲ 1.9% YoY
Gross margin
25.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-09-30
Date not confirmed
Fresenius Medical Care AG (FMS) Q3 2024 Earnings Call Transcript
Positive tone U.S. same market treatment growth Care Enablement and China VBP Operational performance and margin progress
Revenue
4.76B EUR
▼ 3.6% YoY
Diluted EPS
0.73
▲ 151.7% YoY
Gross margin
24.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
Date not confirmed
Fresenius Medical Care AG (FMS) Q2 2024 Earnings Call Transcript
Positive tone Care Delivery volumes and same market treatment growth Mortality and flu/COVID impact FME25 transformation and cost savings
Revenue
4.77B EUR
▼ 1.2% YoY
Diluted EPS
0.64
▲ 33.3% YoY
Gross margin
24.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Date not confirmed
Fresenius Medical Care AG (FMS) Q1 2024 Earnings Call Transcript
Positive tone FME25 transformation program Care Enablement margin inflection Care Delivery transformation
Revenue
4.72B EUR
▲ 0.4% YoY
Diluted EPS
0.24
▼ 17.2% YoY
Gross margin
24.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Date not confirmed
Fresenius Medical Care AG (FMS) Q4 2023 Earnings Call Transcript
Revenue
4.99B EUR*
▼ 0.2% YoY
Gross margin
27.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Date not confirmed
Fresenius Medical Care AG (FMS) Q3 2023 Earnings Call Transcript
Revenue
4.94B EUR
▼ 3.1% YoY
Diluted EPS
0.29
▼ 62.8% YoY
Gross margin
24.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Date not confirmed
Fresenius Medical Care AG (FMS) Q2 2023 Earnings Call Transcript
Revenue
4.83B EUR
▲ 1.4% YoY
Diluted EPS
0.48
▼ 4% YoY
Gross margin
24.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Date not confirmed
Fresenius Medical Care AG (FMS) Q1 2023 Earnings Call Transcript
Revenue
4.70B EUR
▲ 3.4% YoY
Diluted EPS
0.29
▼ 46.3% YoY
Gross margin
24.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Date not confirmed
Fresenius Medical Care AG (FMS) Q4 2022 Earnings Call Transcript
Revenue
5.00B EUR*
▲ 7.5% YoY
Gross margin
27.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Date not confirmed
Fresenius Medical Care AG (FMS) Q3 2022 Earnings Call Transcript
Revenue
5.10B EUR
▲ 14.7% YoY
Diluted EPS
0.78
▼ 16.1% YoY
Gross margin
26.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
Date not confirmed
Fresenius Medical Care AG (FMS) Q1 2022 Earnings Call Transcript
Revenue
4.55B EUR
▲ 8% YoY
Diluted EPS
0.54
▼ 36.5% YoY
Gross margin
27.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
Date not confirmed
Fresenius Medical Care AG (FMS) Q4 2021 Earnings Call Transcript
Revenue
4.65B EUR*
▲ 5.6% YoY
Gross margin
28.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-09-30
Date not confirmed
Fresenius Medical Care AG (FMS) Q3 2021 Earnings Call Transcript
Revenue
4.44B EUR
▲ 0.6% YoY
Diluted EPS
0.93
▼ 23.1% YoY
Gross margin
28.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-06-30
Date not confirmed
Fresenius Medical Care AG (FMS) Q2 2021 Earnings Call Transcript
Revenue
4.32B EUR
▼ 5.2% YoY
Diluted EPS
0.75
▼ 37.5% YoY
Gross margin
29.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-03-31
Date not confirmed
Fresenius Medical Care AG (FMS) Q1 2021 Earnings Call Transcript
Revenue
4.21B EUR
▼ 6.2% YoY
Diluted EPS
0.85
▼ 10.5% YoY
Gross margin
28.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
Date not confirmed
Fresenius Medical Care AG (FMS) Q4 2020 Earnings Call Transcript
Revenue
4.40B EUR*
▼ 3.9% YoY
Gross margin
31.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q2
2020-06-30
Date not confirmed
Fresenius Medical Care AG (FMS) Q2 2020 Earnings Call Transcript
Revenue
4.56B EUR
▲ 4.9% YoY
Diluted EPS
1.20
▲ 42.9% YoY
Gross margin
31.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
Date not confirmed
Fresenius Medical Care AG (FMS) Q1 2020 Earnings Call Transcript
Revenue
4.49B EUR
▲ 8.6% YoY
Diluted EPS
0.95
▲ 8% YoY
Gross margin
31.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–25 of 25 webcasts
Key facts CIK 1333141 CUSIP 358029106 13F (30d) 70 filings 66 filers Visit website Investor relations